HSCA Joins Leading Healthcare Organizations in Supporting the CREATES Act (S.974)
We, the undersigned, commend you for your leadership and commitment to reducing out-of-control prescription drug prices and stopping anti-competitive abuses that keep drug prices high. We are encouraged that the Senate Judiciary Committee has noticed a markup of the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974). We thank you for your efforts to move this important piece of legislation through the Committee.
Related Posts
HSCA Statement on Senate HELP Committee Hearing on Reducing Costs through Innovation
Washington, DC (November 28, 2018) – Healthcare Supply Chain Association (HSCA)...
Comments of the Healthcare Supply Chain Association on the Department of Health and Human Services Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids
Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph.,...